Upstream Bio, Inc. UPB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.32M+16.4% | $2.85M+2.0% | $2.8M+2.8% | $2.72M+18.6% | $2.3M-3.1% | ||
| $147.57M+7.9% | $136.81M+15.5% | $118.41M+17.4% | $100.87M+30.9% | $77.07M+22.4% | ||
| $27.71M+4.9% | $26.41M+6.1% | $24.9M+6.3% | $23.43M+17.2% | $19.99M+16.4% | ||
| $175.29M+7.4% | $163.22M+13.9% | $143.31M+15.3% | $124.29M+28.1% | $97.06M+21.1% | ||
| -$171.96M-7.2% | -$160.36M-14.1% | -$140.51M-15.6% | -$121.57M-28.3% | -$94.76M-21.9% | ||
| -5,176.5%+442pp | -5,618.8%-599pp | -5,020.1%-555pp | -4,464.6%-337pp | -4,127.4%-846pp | ||
| $15.2M-10.2% | $16.92M-7.5% | $18.29M+6.9% | $17.1M+9.7% | $15.58M+4.2% | ||
| -$156.76M-9.3% | -$143.44M-17.4% | -$122.23M-17.0% | -$104.47M-31.9% | -$79.18M-26.1% | ||
| -4,719%+307pp | -5,026%-659pp | -4,366.8%-530pp | -3,836.6%-388pp | -3,448.7%-799pp | ||
| -$2.90-9.0% | -$2.66— | —— | —— | —— | ||
| -$171.77M-7.2% | -$160.17M-14.1% | -$140.33M-15.6% | -$121.42M-28.3% | -$94.65M-21.8% | ||
| -5,170.7%+442pp | -5,612.2%-599pp | -5,013.6%-554pp | -4,459.2%-337pp | -4,122.2%-845pp | ||
| -$171.96M-7.2% | -$160.36M-14.1% | -$140.51M-15.6% | -$121.57M-28.3% | -$94.76M-21.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Upstream Bio, Inc.'s revenue?
- Upstream Bio, Inc. (UPB) generated $3.3M in revenue over the trailing twelve months, up 44.7% year over year.
- Is Upstream Bio, Inc. profitable?
- Upstream Bio, Inc. is not currently profitable: it reported a net loss of $156.8M over the trailing twelve months, a -4719.0% net margin.
- What is Upstream Bio, Inc.'s earnings per share?
- Upstream Bio, Inc.'s diluted EPS over the trailing twelve months is $-2.90.
- Where does Upstream Bio, Inc.'s income statement data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
